Theralase Technologies Inc. (TLTFF) Financials
TLTFF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 2.8 million | 1.4 million |
| Dec. 31, 2025 | 2.5 million | 1.3 million |
| Sept. 30, 2025 | 2.2 million | 1.4 million |
| June 30, 2025 | 2.2 million | 1.3 million |
TLTFF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -176464 | ? |
| Dec. 31, 2025 | -865059 | 45940 |
| Sept. 30, 2025 | -504351 | 116349 |
| June 30, 2025 | -760013 | 117774 |
TLTFF Net Income
No data available :(
TLTFF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 721808 | - | 67167 |
| Dec. 31, 2025 | 133417 | - | 147424 |
| Sept. 30, 2025 | 58162 | 81132 | 157797 |
| June 30, 2025 | 34046 | 122681 | 179968 |
TLTFF Shares Outstanding
TLTFF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 645 | 375691 | 368836 | - |
| Dec. 31, 2025 | 30660 | 245009 | 374093 | -59737 |
| Sept. 30, 2025 | 10880 | 471189 | 375435 | 52721 |
| June 30, 2025 | 8263 | 428315 | 375656 | 52084 |
TLTFF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 95359 | 91679 |
| Dec. 31, 2025 | 164768 | 6997 |
| Sept. 30, 2025 | 200830 | 86738 |
| June 30, 2025 | 161501 | 74282 |
TLTFF
Price: $0.16
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -21
Exchange: OQB
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 51.5 million